全体要約
2023年の世界の嚢胞性線維症治療薬市場は、4950.4百万米ドルと評価され、2030年には12390百万米ドルに達する見込みで、年平均成長率（CAGR）は14.0%です。市場の成長には、製品の差別化やコスト削減、サプライチェーンの最適化が重要です。企業は研究開発に投資し、戦略的パートナーシップを結ぶ必要があります。
製薬市場は2022年に1475億米ドルで、今後6年間で年平均成長率5%で成長すると予測されています。生物製剤市場は3810億米ドルに達し、化学薬品市場は2018年の1005億米ドルから2022年には1094億米ドルに増加します。市場は、医療需要の増加や技術革新、慢性疾患の増加に影響されますが、厳しい規制や高い研究開発コスト、特許の期限切れなどの課題にも直面しています。
関連する質問
4950.4百万米ドル（2023年）
14.0%（2023年から2030年）
Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, AstraZeneca, Bayer, Celtaxsys, Pharmaxis, ProQR Therapeutics, PTC Therapeutics, Alcresta Therapeutics, Insmed Incorporated, Savara, Cyclacel Pharmaceuticals, Vectura, Allergan
製品の差別化, コスト削減, サプライチェーンの最適化
概要
この研究報告は、世界の嚢胞性線維症治療薬市場の成長可能性を強調しています。嚢胞性線維症治療薬は、今後の市場で安定した成長を示すと予想されています。しかし、製品の差別化、コスト削減、サプライチェーンの最適化は、嚢胞性線維症治療薬の普及にとって重要な課題であり続けます。市場のプレーヤーは、研究開発に投資し、戦略的パートナーシップを形成し、進化する消費者の嗜好に合わせた提供を行うことで、嚢胞性線維症治療薬市場がもたらす膨大な機会を活用する必要があります。
2022年の全球製薬市場は1475億米ドルであり、今後6年間で年平均成長率（CAGR）5%で成長すると予測されています。製薬市場には化学薬品とバイオ薬品が含まれています。バイオ製品は2022年に381億米ドルに達すると予想されています。それに対し、化学薬品市場は2018年の1005億米ドルから2022年には1094億米ドルに増加すると見込まれています。製薬市場の要因としては、医療への需要の増加、技術の進歩、慢性疾患の増加、製薬製造部門の開発のための民間および政府からの資金増加、医薬品の研究開発活動の増加があります。しかしながら、この業界は厳しい規制、高い研究開発コスト、特許の失効といった課題にも直面しています。企業は市場で競争力を維持し、患者に必要な製品が届くように、これらの課題に適応し続ける必要があります。さらに、COVID-19パンデミックはワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに迅速に対応する必要性をさらに強調しています。
主な特徴：
嚢胞性線維症治療市場に関する報告書は、さまざまな側面を反映し、業界に貴重な洞察を提供します。
市場規模と成長：この調査報告書では、嚢胞性線維症治療薬市場の現在の規模と成長についての概要を提供。歴史的データ、タイプ別の市場セグメンテーション（例：CFTR、粘液溶解剤）、地域別の内訳が含まれる可能性があります。
市場の推進要因と課題：レポートは、政府の規制、環境問題、技術の進歩、消費者の嗜好の変化など、嚢胞性線維症治療薬市場の成長を促進する要因を特定し分析することができます。また、インフラの制限、レンジ不安、高い初期費用など、業界が直面している課題を強調することも可能です。
競争環境: 本調査報告書は、嚢胞性線維症治療薬市場における競争環境の分析を提供します。主要なプレーヤーのプロフィール、市場シェア、戦略、製品提供が含まれています。また、報告書は、新興プレーヤーとその市場への潜在的な影響も強調することができます。
技術的進展：この研究報告は、嚢胞性線維症治療薬業界における最新の技術的進展を深く掘り下げることができます。これには、嚢胞性線維症治療薬技術の進歩、新たな参入者、新たな投資、そして嚢胞性線維症治療薬の未来を形作るその他の革新が含まれます。
ダウンストリームプロカンベントの選好：この報告書は、嚢胞性線維症治療薬市場における顧客のプロカンベント行動と採用傾向について明らかにすることができます。顧客の購買決定に影響を与える要因や、嚢胞性線維症治療薬の商品に対する好みが含まれています。
政府の政策とインセンティブ：この調査報告書は、嚢胞性線維症治療薬市場に対する政府の政策とインセンティブの影響を分析しています。これには、規制枠組み、補助金、税制優遇措置、および嚢胞性線維症治療薬市場を促進することを目的としたその他の手段の評価が含まれる場合があります。また、報告書では、これらの政策が市場成長を促進する効果についても評価しています。
環境影響と持続可能性：本研究報告書は、嚢胞性線維症治療薬市場の環境影響および持続可能性の側面を評価しています。
市場予測と将来の見通し：行われた分析に基づいて、研究報告は嚢胞性線維症治療薬産業の市場予測と見通しを提供します。これには市場規模、成長率、地域動向、技術の進展や政策の動向に関する予測が含まれます。
推奨事項と機会：この報告書は、業界関係者、政策立案者、投資家に対する推奨事項で締めくくられています。新たなトレンドを活かし、課題を克服し、嚢胞性線維症治療薬市場の成長と発展に貢献するための市場プレイヤーにとっての潜在的な機会を強調しています。
市場セグメンテーション
嚢胞性線維症治療薬市場は、タイプとアプリケーションによって分かれています。2019年から2030年の期間において、セグメント間の成長は、タイプ別およびアプリケーション別の消費価値について正確な計算と予測を提供します。
タイプ別セグメンテーション
CFTR
去痰薬
パート
抗感染剤
気管支拡張薬
用途別のセグメンテーション
病院
クリニック
この報告書では、市場を地域別に分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
APAC（アジア太平洋地域）
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下のプロファイルに示されている企業は、主要な専門家からの情報と、企業のカバレッジ、製品ポートフォリオ、市場浸透の分析に基づいて選定されています。
バーテックス・ファーマシューティカルズ
F. ホフマン・ラ・ロッシュ
アッヴィ
ギリアド・サイエンシズ
ノバルティス
アストラゼネカ
バイエル
セルタクシス
ファーマクシス
プロQRセラピューティクス
PTCセラピューティクス
アルクレスタセラピューティクス
インスミッド社
サバラ
サイクラセル・ファーマシューティカルズ
ベクチュラ
アラガン
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの嚢胞性線維症治療薬市場規模、（2019年～2030年）
2.1.2 嚢胞性線維症治療薬市場規模、CAGR（地域別）（2019年 vs 2023年 vs 2030年）
2.2 嚢胞性線維症治療薬セグメント、タイプ別
2.2.1 Cftr
2.2.2 粘液溶解剤
2.2.3 ペート
2.2.4 抗感染症薬
2.2.5 気管支拡張薬
2.3 嚢胞性線維症治療薬市場規模：タイプ別
2.3.1 嚢胞性線維症治療薬市場規模、CAGR（タイプ別）（2019年 vs 2023年 vs 2030年）
2.3.2 グローバルの嚢胞性線維症治療薬市場規模、市場シェア（タイプ別）（2019年～2024年）
2.4 嚢胞性線維症治療薬セグメント、用途別
2.4.1 病院
2.4.2 クリニック
2.5 嚢胞性線維症治療薬市場規模：用途別
2.5.1 嚢胞性線維症治療薬市場規模、CAGR（用途別）（2019年 vs 2023年 vs 2030年）
2.5.2 グローバルの嚢胞性線維症治療薬市場規模、市場シェア（用途別）（2019年～2024年）
3 嚢胞性線維症治療薬市場規模：プレイヤー別
3.1 嚢胞性線維症治療薬市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける嚢胞性線維症治療薬市場の収益規模、プレイヤー別（2019年～2024年）
3.1.2 グローバルにおける嚢胞性線維症治療薬市場の収益シェア、プレイヤー別（2019年～2024年）
3.2 グローバルの嚢胞性線維症治療薬市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2022年～2024年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 嚢胞性線維症治療薬、地域別
4.1 嚢胞性線維症治療薬市場規模（地域別）（2019年～2024年）
4.2 アメリカズにおける嚢胞性線維症治療薬市場規模成長（2019年〜2024年）
4.3 APACにおける嚢胞性線維症治療薬市場規模成長（2019年〜2024年）
4.4 ヨーロッパにおける嚢胞性線維症治療薬市場規模成長（2019年〜2024年）
4.5 中東・アフリカにおける嚢胞性線維症治療薬市場規模成長（2019年〜2024年）
5 アメリカズ
5.1 アメリカズにおける嚢胞性線維症治療薬市場規模、国別（2019年〜2024年）
5.2 アメリカズにおける嚢胞性線維症治療薬市場規模、タイプ別（2019年〜2024年）
5.3 アメリカズにおける嚢胞性線維症治療薬市場規模、用途別（2019年〜2024年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける嚢胞性線維症治療薬市場規模、地域別（2019年〜2024年）
6.2 APACにおける嚢胞性線維症治療薬市場規模、タイプ別（2019年〜2024年）
6.3 APACにおける嚢胞性線維症治療薬市場規模、用途別（2019年〜2024年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの嚢胞性線維症治療薬 国別（2019年～2024年）
7.2 ヨーロッパにおける嚢胞性線維症治療薬市場規模、タイプ別（2019年〜2024年）
7.3 ヨーロッパにおける嚢胞性線維症治療薬市場規模、用途別（2019年〜2024年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの嚢胞性線維症治療薬 地域別（2019年～2024年）
8.2 中東・アフリカにおける嚢胞性線維症治療薬市場規模、タイプ別（2019年〜2024年）
8.3 中東・アフリカにおける嚢胞性線維症治療薬市場規模、用途別（2019年〜2024年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの嚢胞性線維症治療薬市場、市場予測
10.1 グローバルの嚢胞性線維症治療薬、市場予測（地域別）（2025年～2030年）
10.1.1 グローバルの嚢胞性線維症治療薬、市場予測（地域別）（2025年～2030年）
10.1.2 アメリカズの嚢胞性線維症治療薬、市場予測
10.1.3 APACの嚢胞性線維症治療薬、市場予測
10.1.4 ヨーロッパの嚢胞性線維症治療薬、市場予測
10.1.5 中東・アフリカの嚢胞性線維症治療薬、市場予測
10.2 アメリカズの嚢胞性線維症治療薬、市場予測（国別）（2025年～2030年）
10.3 APACの嚢胞性線維症治療薬、市場予測（地域別）（2025年～2030年）
10.4 ヨーロッパの嚢胞性線維症治療薬、市場予測（国別）（2025年～2030年）
10.5 中東・アフリカの嚢胞性線維症治療薬、市場予測（地域別）（2025年～2030年）
10.6 グローバルの嚢胞性線維症治療薬、市場予測（タイプ別）（2025年～2030年）
10.7 グローバルの嚢胞性線維症治療薬、市場予測（用途別）（2025年～2030年）
11 キープレイヤー分析
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals：企業情報
11.1.2 Vertex Pharmaceuticals：嚢胞性線維症治療薬分野の提供製品
11.1.3 Vertex Pharmaceuticals：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.1.4 Vertex Pharmaceuticals：主要事業概要
11.1.5 Vertex Pharmaceuticals：直近の展開
11.2 F\. Hoffmann-La Roche
11.2.1 F\. Hoffmann-La Roche：企業情報
11.2.2 F\. Hoffmann-La Roche：嚢胞性線維症治療薬分野の提供製品
11.2.3 F\. Hoffmann-La Roche：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.2.4 F\. Hoffmann-La Roche：主要事業概要
11.2.5 F\. Hoffmann-La Roche：直近の展開
11.3 AbbVie
11.3.1 AbbVie：企業情報
11.3.2 AbbVie：嚢胞性線維症治療薬分野の提供製品
11.3.3 AbbVie：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.3.4 AbbVie：主要事業概要
11.3.5 AbbVie：直近の展開
11.4 Gilead Sciences
11.4.1 Gilead Sciences：企業情報
11.4.2 Gilead Sciences：嚢胞性線維症治療薬分野の提供製品
11.4.3 Gilead Sciences：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.4.4 Gilead Sciences：主要事業概要
11.4.5 Gilead Sciences：直近の展開
11.5 Novartis
11.5.1 Novartis：企業情報
11.5.2 Novartis：嚢胞性線維症治療薬分野の提供製品
11.5.3 Novartis：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.5.4 Novartis：主要事業概要
11.5.5 Novartis：直近の展開
11.6 AstraZeneca
11.6.1 AstraZeneca：企業情報
11.6.2 AstraZeneca：嚢胞性線維症治療薬分野の提供製品
11.6.3 AstraZeneca：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.6.4 AstraZeneca：主要事業概要
11.6.5 AstraZeneca：直近の展開
11.7 Bayer
11.7.1 Bayer：企業情報
11.7.2 Bayer：嚢胞性線維症治療薬分野の提供製品
11.7.3 Bayer：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.7.4 Bayer：主要事業概要
11.7.5 Bayer：直近の展開
11.8 Celtaxsys
11.8.1 Celtaxsys：企業情報
11.8.2 Celtaxsys：嚢胞性線維症治療薬分野の提供製品
11.8.3 Celtaxsys：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.8.4 Celtaxsys：主要事業概要
11.8.5 Celtaxsys：直近の展開
11.9 Pharmaxis
11.9.1 Pharmaxis：企業情報
11.9.2 Pharmaxis：嚢胞性線維症治療薬分野の提供製品
11.9.3 Pharmaxis：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.9.4 Pharmaxis：主要事業概要
11.9.5 Pharmaxis：直近の展開
11.10 ProQR Therapeutics
11.10.1 ProQR Therapeutics：企業情報
11.10.2 ProQR Therapeutics：嚢胞性線維症治療薬分野の提供製品
11.10.3 ProQR Therapeutics：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.10.4 ProQR Therapeutics：主要事業概要
11.10.5 ProQR Therapeutics：直近の展開
11.11 PTC Therapeutics
11.11.1 PTC Therapeutics：企業情報
11.11.2 PTC Therapeutics：嚢胞性線維症治療薬分野の提供製品
11.11.3 PTC Therapeutics：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.11.4 PTC Therapeutics：主要事業概要
11.11.5 PTC Therapeutics：直近の展開
11.12 Alcresta Therapeutics
11.12.1 Alcresta Therapeutics：企業情報
11.12.2 Alcresta Therapeutics：嚢胞性線維症治療薬分野の提供製品
11.12.3 Alcresta Therapeutics：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.12.4 Alcresta Therapeutics：主要事業概要
11.12.5 Alcresta Therapeutics：直近の展開
11.13 Insmed Incorporated
11.13.1 Insmed Incorporated：企業情報
11.13.2 Insmed Incorporated：嚢胞性線維症治療薬分野の提供製品
11.13.3 Insmed Incorporated：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.13.4 Insmed Incorporated：主要事業概要
11.13.5 Insmed Incorporated：直近の展開
11.14 Savara
11.14.1 Savara：企業情報
11.14.2 Savara：嚢胞性線維症治療薬分野の提供製品
11.14.3 Savara：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.14.4 Savara：主要事業概要
11.14.5 Savara：直近の展開
11.15 Cyclacel Pharmaceuticals
11.15.1 Cyclacel Pharmaceuticals：企業情報
11.15.2 Cyclacel Pharmaceuticals：嚢胞性線維症治療薬分野の提供製品
11.15.3 Cyclacel Pharmaceuticals：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.15.4 Cyclacel Pharmaceuticals：主要事業概要
11.15.5 Cyclacel Pharmaceuticals：直近の展開
11.16 Vectura
11.16.1 Vectura：企業情報
11.16.2 Vectura：嚢胞性線維症治療薬分野の提供製品
11.16.3 Vectura：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.16.4 Vectura：主要事業概要
11.16.5 Vectura：直近の展開
11.17 Allergan
11.17.1 Allergan：企業情報
11.17.2 Allergan：嚢胞性線維症治療薬分野の提供製品
11.17.3 Allergan：嚢胞性線維症治療薬収益・グロスマージンおよび市場シェア（2019年～2024年）
11.17.4 Allergan：主要事業概要
11.17.5 Allergan：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
The research report highlights the growth potential of the global Cystic Fibrosis Therapeutics market. Cystic Fibrosis Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cystic Fibrosis Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cystic Fibrosis Therapeutics market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Cystic Fibrosis Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cystic Fibrosis Therapeutics market. It may include historical data, market segmentation by Type (e.g., CFTR, Mucolytics), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cystic Fibrosis Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cystic Fibrosis Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cystic Fibrosis Therapeutics industry. This include advancements in Cystic Fibrosis Therapeutics technology, Cystic Fibrosis Therapeutics new entrants, Cystic Fibrosis Therapeutics new investment, and other innovations that are shaping the future of Cystic Fibrosis Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cystic Fibrosis Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Cystic Fibrosis Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cystic Fibrosis Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cystic Fibrosis Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cystic Fibrosis Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cystic Fibrosis Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cystic Fibrosis Therapeutics market.
Market Segmentation:
Cystic Fibrosis Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
CFTR
Mucolytics
PERT
Anti-infectives
Bronchodilators
Segmentation by application
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Vertex Pharmaceuticals
F. Hoffmann-La Roche
AbbVie
Gilead Sciences
Novartis
AstraZeneca
Bayer
Celtaxsys
Pharmaxis
ProQR Therapeutics
PTC Therapeutics
Alcresta Therapeutics
Insmed Incorporated
Savara
Cyclacel Pharmaceuticals
Vectura
Allergan
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cystic Fibrosis Therapeutics Market Size 2019-2030
2.1.2 Cystic Fibrosis Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cystic Fibrosis Therapeutics Segment by Type
2.2.1 CFTR
2.2.2 Mucolytics
2.2.3 PERT
2.2.4 Anti-infectives
2.2.5 Bronchodilators
2.3 Cystic Fibrosis Therapeutics Market Size by Type
2.3.1 Cystic Fibrosis Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cystic Fibrosis Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Cystic Fibrosis Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Cystic Fibrosis Therapeutics Market Size by Application
2.5.1 Cystic Fibrosis Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cystic Fibrosis Therapeutics Market Size Market Share by Application (2019-2024)
3 Cystic Fibrosis Therapeutics Market Size by Player
3.1 Cystic Fibrosis Therapeutics Market Size Market Share by Players
3.1.1 Global Cystic Fibrosis Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Cystic Fibrosis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Cystic Fibrosis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cystic Fibrosis Therapeutics by Regions
4.1 Cystic Fibrosis Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Cystic Fibrosis Therapeutics Market Size Growth (2019-2024)
4.3 APAC Cystic Fibrosis Therapeutics Market Size Growth (2019-2024)
4.4 Europe Cystic Fibrosis Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Cystic Fibrosis Therapeutics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Cystic Fibrosis Therapeutics Market Size by Country (2019-2024)
5.2 Americas Cystic Fibrosis Therapeutics Market Size by Type (2019-2024)
5.3 Americas Cystic Fibrosis Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cystic Fibrosis Therapeutics Market Size by Region (2019-2024)
6.2 APAC Cystic Fibrosis Therapeutics Market Size by Type (2019-2024)
6.3 APAC Cystic Fibrosis Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cystic Fibrosis Therapeutics by Country (2019-2024)
7.2 Europe Cystic Fibrosis Therapeutics Market Size by Type (2019-2024)
7.3 Europe Cystic Fibrosis Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cystic Fibrosis Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cystic Fibrosis Therapeutics Market Forecast
10.1 Global Cystic Fibrosis Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Cystic Fibrosis Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Cystic Fibrosis Therapeutics Forecast
10.1.3 APAC Cystic Fibrosis Therapeutics Forecast
10.1.4 Europe Cystic Fibrosis Therapeutics Forecast
10.1.5 Middle East & Africa Cystic Fibrosis Therapeutics Forecast
10.2 Americas Cystic Fibrosis Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Cystic Fibrosis Therapeutics Market Forecast
10.2.2 Canada Cystic Fibrosis Therapeutics Market Forecast
10.2.3 Mexico Cystic Fibrosis Therapeutics Market Forecast
10.2.4 Brazil Cystic Fibrosis Therapeutics Market Forecast
10.3 APAC Cystic Fibrosis Therapeutics Forecast by Region (2025-2030)
10.3.1 China Cystic Fibrosis Therapeutics Market Forecast
10.3.2 Japan Cystic Fibrosis Therapeutics Market Forecast
10.3.3 Korea Cystic Fibrosis Therapeutics Market Forecast
10.3.4 Southeast Asia Cystic Fibrosis Therapeutics Market Forecast
10.3.5 India Cystic Fibrosis Therapeutics Market Forecast
10.3.6 Australia Cystic Fibrosis Therapeutics Market Forecast
10.4 Europe Cystic Fibrosis Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Cystic Fibrosis Therapeutics Market Forecast
10.4.2 France Cystic Fibrosis Therapeutics Market Forecast
10.4.3 UK Cystic Fibrosis Therapeutics Market Forecast
10.4.4 Italy Cystic Fibrosis Therapeutics Market Forecast
10.4.5 Russia Cystic Fibrosis Therapeutics Market Forecast
10.5 Middle East & Africa Cystic Fibrosis Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Cystic Fibrosis Therapeutics Market Forecast
10.5.2 South Africa Cystic Fibrosis Therapeutics Market Forecast
10.5.3 Israel Cystic Fibrosis Therapeutics Market Forecast
10.5.4 Turkey Cystic Fibrosis Therapeutics Market Forecast
10.5.5 GCC Countries Cystic Fibrosis Therapeutics Market Forecast
10.6 Global Cystic Fibrosis Therapeutics Forecast by Type (2025-2030)
10.7 Global Cystic Fibrosis Therapeutics Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals Company Information
11.1.2 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product Offered
11.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Vertex Pharmaceuticals Main Business Overview
11.1.5 Vertex Pharmaceuticals Latest Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product Offered
11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 F. Hoffmann-La Roche Main Business Overview
11.2.5 F. Hoffmann-La Roche Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Cystic Fibrosis Therapeutics Product Offered
11.3.3 AbbVie Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences Cystic Fibrosis Therapeutics Product Offered
11.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Cystic Fibrosis Therapeutics Product Offered
11.5.3 Novartis Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Cystic Fibrosis Therapeutics Product Offered
11.6.3 AstraZeneca Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Cystic Fibrosis Therapeutics Product Offered
11.7.3 Bayer Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bayer Main Business Overview
11.7.5 Bayer Latest Developments
11.8 Celtaxsys
11.8.1 Celtaxsys Company Information
11.8.2 Celtaxsys Cystic Fibrosis Therapeutics Product Offered
11.8.3 Celtaxsys Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Celtaxsys Main Business Overview
11.8.5 Celtaxsys Latest Developments
11.9 Pharmaxis
11.9.1 Pharmaxis Company Information
11.9.2 Pharmaxis Cystic Fibrosis Therapeutics Product Offered
11.9.3 Pharmaxis Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Pharmaxis Main Business Overview
11.9.5 Pharmaxis Latest Developments
11.10 ProQR Therapeutics
11.10.1 ProQR Therapeutics Company Information
11.10.2 ProQR Therapeutics Cystic Fibrosis Therapeutics Product Offered
11.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 ProQR Therapeutics Main Business Overview
11.10.5 ProQR Therapeutics Latest Developments
11.11 PTC Therapeutics
11.11.1 PTC Therapeutics Company Information
11.11.2 PTC Therapeutics Cystic Fibrosis Therapeutics Product Offered
11.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 PTC Therapeutics Main Business Overview
11.11.5 PTC Therapeutics Latest Developments
11.12 Alcresta Therapeutics
11.12.1 Alcresta Therapeutics Company Information
11.12.2 Alcresta Therapeutics Cystic Fibrosis Therapeutics Product Offered
11.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Alcresta Therapeutics Main Business Overview
11.12.5 Alcresta Therapeutics Latest Developments
11.13 Insmed Incorporated
11.13.1 Insmed Incorporated Company Information
11.13.2 Insmed Incorporated Cystic Fibrosis Therapeutics Product Offered
11.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Insmed Incorporated Main Business Overview
11.13.5 Insmed Incorporated Latest Developments
11.14 Savara
11.14.1 Savara Company Information
11.14.2 Savara Cystic Fibrosis Therapeutics Product Offered
11.14.3 Savara Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Savara Main Business Overview
11.14.5 Savara Latest Developments
11.15 Cyclacel Pharmaceuticals
11.15.1 Cyclacel Pharmaceuticals Company Information
11.15.2 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product Offered
11.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Cyclacel Pharmaceuticals Main Business Overview
11.15.5 Cyclacel Pharmaceuticals Latest Developments
11.16 Vectura
11.16.1 Vectura Company Information
11.16.2 Vectura Cystic Fibrosis Therapeutics Product Offered
11.16.3 Vectura Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Vectura Main Business Overview
11.16.5 Vectura Latest Developments
11.17 Allergan
11.17.1 Allergan Company Information
11.17.2 Allergan Cystic Fibrosis Therapeutics Product Offered
11.17.3 Allergan Cystic Fibrosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Allergan Main Business Overview
11.17.5 Allergan Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Cystic Fibrosis Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions) Table 2. Major Players of CFTR Table 3. Major Players of Mucolytics Table 4. Major Players of PERT Table 5. Major Players of Anti-infectives Table 6. Major Players of Bronchodilators Table 7. Cystic Fibrosis Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions) Table 8. Global Cystic Fibrosis Therapeutics Market Size by Type (2019-2024) & ($ Millions) Table 9. Global Cystic Fibrosis Therapeutics Market Size Market Share by Type (2019-2024) Table 10. Cystic Fibrosis Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions) Table 11. Global Cystic Fibrosis Therapeutics Market Size by Application (2019-2024) & ($ Millions) Table 12. Global Cystic Fibrosis Therapeutics Market Size Market Share by Application (2019-2024) Table 13. Global Cystic Fibrosis Therapeutics Revenue by Players (2019-2024) & ($ Millions) Table 14. Global Cystic Fibrosis Therapeutics Revenue Market Share by Player (2019-2024) Table 15. Cystic Fibrosis Therapeutics Key Players Head office and Products Offered Table 16. Cystic Fibrosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Cystic Fibrosis Therapeutics Market Size by Regions 2019-2024 & ($ Millions) Table 20. Global Cystic Fibrosis Therapeutics Market Size Market Share by Regions (2019-2024) Table 21. Global Cystic Fibrosis Therapeutics Revenue by Country/Region (2019-2024) & ($ millions) Table 22. Global Cystic Fibrosis Therapeutics Revenue Market Share by Country/Region (2019-2024) Table 23. Americas Cystic Fibrosis Therapeutics Market Size by Country (2019-2024) & ($ Millions) Table 24. Americas Cystic Fibrosis Therapeutics Market Size Market Share by Country (2019-2024) Table 25. Americas Cystic Fibrosis Therapeutics Market Size by Type (2019-2024) & ($ Millions) Table 26. Americas Cystic Fibrosis Therapeutics Market Size Market Share by Type (2019-2024) Table 27. Americas Cystic Fibrosis Therapeutics Market Size by Application (2019-2024) & ($ Millions) Table 28. Americas Cystic Fibrosis Therapeutics Market Size Market Share by Application (2019-2024) Table 29. APAC Cystic Fibrosis Therapeutics Market Size by Region (2019-2024) & ($ Millions) Table 30. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Region (2019-2024) Table 31. APAC Cystic Fibrosis Therapeutics Market Size by Type (2019-2024) & ($ Millions) Table 32. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Type (2019-2024) Table 33. APAC Cystic Fibrosis Therapeutics Market Size by Application (2019-2024) & ($ Millions) Table 34. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Application (2019-2024) Table 35. Europe Cystic Fibrosis Therapeutics Market Size by Country (2019-2024) & ($ Millions) Table 36. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Country (2019-2024) Table 37. Europe Cystic Fibrosis Therapeutics Market Size by Type (2019-2024) & ($ Millions) Table 38. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Type (2019-2024) Table 39. Europe Cystic Fibrosis Therapeutics Market Size by Application (2019-2024) & ($ Millions) Table 40. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Application (2019-2024) Table 41. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Region (2019-2024) & ($ Millions) Table 42. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Region (2019-2024) Table 43. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Type (2019-2024) & ($ Millions) Table 44. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Type (2019-2024) Table 45. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Application (2019-2024) & ($ Millions) Table 46. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Application (2019-2024) Table 47. Key Market Drivers & Growth Opportunities of Cystic Fibrosis Therapeutics Table 48. Key Market Challenges & Risks of Cystic Fibrosis Therapeutics Table 49. Key Industry Trends of Cystic Fibrosis Therapeutics Table 50. Global Cystic Fibrosis Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions) Table 51. Global Cystic Fibrosis Therapeutics Market Size Market Share Forecast by Regions (2025-2030) Table 52. Global Cystic Fibrosis Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions) Table 53. Global Cystic Fibrosis Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions) Table 54. Vertex Pharmaceuticals Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 55. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product Offered Table 56. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 57. Vertex Pharmaceuticals Main Business Table 58. Vertex Pharmaceuticals Latest Developments Table 59. F. Hoffmann-La Roche Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 60. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product Offered Table 61. F. Hoffmann-La Roche Main Business Table 62. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 63. F. Hoffmann-La Roche Latest Developments Table 64. AbbVie Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 65. AbbVie Cystic Fibrosis Therapeutics Product Offered Table 66. AbbVie Main Business Table 67. AbbVie Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 68. AbbVie Latest Developments Table 69. Gilead Sciences Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 70. Gilead Sciences Cystic Fibrosis Therapeutics Product Offered Table 71. Gilead Sciences Main Business Table 72. Gilead Sciences Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 73. Gilead Sciences Latest Developments Table 74. Novartis Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 75. Novartis Cystic Fibrosis Therapeutics Product Offered Table 76. Novartis Main Business Table 77. Novartis Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 78. Novartis Latest Developments Table 79. AstraZeneca Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 80. AstraZeneca Cystic Fibrosis Therapeutics Product Offered Table 81. AstraZeneca Main Business Table 82. AstraZeneca Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 83. AstraZeneca Latest Developments Table 84. Bayer Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 85. Bayer Cystic Fibrosis Therapeutics Product Offered Table 86. Bayer Main Business Table 87. Bayer Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 88. Bayer Latest Developments Table 89. Celtaxsys Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 90. Celtaxsys Cystic Fibrosis Therapeutics Product Offered Table 91. Celtaxsys Main Business Table 92. Celtaxsys Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 93. Celtaxsys Latest Developments Table 94. Pharmaxis Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 95. Pharmaxis Cystic Fibrosis Therapeutics Product Offered Table 96. Pharmaxis Main Business Table 97. Pharmaxis Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 98. Pharmaxis Latest Developments Table 99. ProQR Therapeutics Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 100. ProQR Therapeutics Cystic Fibrosis Therapeutics Product Offered Table 101. ProQR Therapeutics Main Business Table 102. ProQR Therapeutics Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 103. ProQR Therapeutics Latest Developments Table 104. PTC Therapeutics Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 105. PTC Therapeutics Cystic Fibrosis Therapeutics Product Offered Table 106. PTC Therapeutics Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 107. PTC Therapeutics Main Business Table 108. PTC Therapeutics Latest Developments Table 109. Alcresta Therapeutics Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 110. Alcresta Therapeutics Cystic Fibrosis Therapeutics Product Offered Table 111. Alcresta Therapeutics Main Business Table 112. Alcresta Therapeutics Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 113. Alcresta Therapeutics Latest Developments Table 114. Insmed Incorporated Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 115. Insmed Incorporated Cystic Fibrosis Therapeutics Product Offered Table 116. Insmed Incorporated Main Business Table 117. Insmed Incorporated Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 118. Insmed Incorporated Latest Developments Table 119. Savara Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 120. Savara Cystic Fibrosis Therapeutics Product Offered Table 121. Savara Main Business Table 122. Savara Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 123. Savara Latest Developments Table 124. Cyclacel Pharmaceuticals Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 125. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product Offered Table 126. Cyclacel Pharmaceuticals Main Business Table 127. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 128. Cyclacel Pharmaceuticals Latest Developments Table 129. Vectura Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 130. Vectura Cystic Fibrosis Therapeutics Product Offered Table 131. Vectura Main Business Table 132. Vectura Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 133. Vectura Latest Developments Table 134. Allergan Details, Company Type, Cystic Fibrosis Therapeutics Area Served and Its Competitors Table 135. Allergan Cystic Fibrosis Therapeutics Product Offered Table 136. Allergan Main Business Table 137. Allergan Cystic Fibrosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 138. Allergan Latest Developments List of Figures Figure 1. Cystic Fibrosis Therapeutics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Cystic Fibrosis Therapeutics Market Size Growth Rate 2019-2030 ($ Millions) Figure 6. Cystic Fibrosis Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Cystic Fibrosis Therapeutics Sales Market Share by Country/Region (2023) Figure 8. Cystic Fibrosis Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Cystic Fibrosis Therapeutics Market Size Market Share by Type in 2023 Figure 10. Cystic Fibrosis Therapeutics in Hospitals Figure 11. Global Cystic Fibrosis Therapeutics Market: Hospitals (2019-2024) & ($ Millions) Figure 12. Cystic Fibrosis Therapeutics in Clinics Figure 13. Global Cystic Fibrosis Therapeutics Market: Clinics (2019-2024) & ($ Millions) Figure 14. Global Cystic Fibrosis Therapeutics Market Size Market Share by Application in 2023 Figure 15. Global Cystic Fibrosis Therapeutics Revenue Market Share by Player in 2023 Figure 16. Global Cystic Fibrosis Therapeutics Market Size Market Share by Regions (2019-2024) Figure 17. Americas Cystic Fibrosis Therapeutics Market Size 2019-2024 ($ Millions) Figure 18. APAC Cystic Fibrosis Therapeutics Market Size 2019-2024 ($ Millions) Figure 19. Europe Cystic Fibrosis Therapeutics Market Size 2019-2024 ($ Millions) Figure 20. Middle East & Africa Cystic Fibrosis Therapeutics Market Size 2019-2024 ($ Millions) Figure 21. Americas Cystic Fibrosis Therapeutics Value Market Share by Country in 2023 Figure 22. United States Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 23. Canada Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 24. Mexico Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 25. Brazil Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 26. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Region in 2023 Figure 27. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Type in 2023 Figure 28. APAC Cystic Fibrosis Therapeutics Market Size Market Share by Application in 2023 Figure 29. China Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 30. Japan Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 31. Korea Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 32. Southeast Asia Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 33. India Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 34. Australia Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 35. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Country in 2023 Figure 36. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Type (2019-2024) Figure 37. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Application (2019-2024) Figure 38. Germany Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 39. France Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 40. UK Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 41. Italy Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 42. Russia Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 43. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Region (2019-2024) Figure 44. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Type (2019-2024) Figure 45. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Market Share by Application (2019-2024) Figure 46. Egypt Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 47. South Africa Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 48. Israel Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 49. Turkey Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 50. GCC Country Cystic Fibrosis Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 51. Americas Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 52. APAC Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 53. Europe Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 54. Middle East & Africa Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 55. United States Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 56. Canada Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 57. Mexico Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 58. Brazil Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 59. China Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 60. Japan Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 61. Korea Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 62. Southeast Asia Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 63. India Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 64. Australia Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 65. Germany Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 66. France Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 67. UK Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 68. Italy Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 69. Russia Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 70. Spain Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 71. Egypt Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 72. South Africa Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 73. Israel Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 74. Turkey Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 75. GCC Countries Cystic Fibrosis Therapeutics Market Size 2025-2030 ($ Millions) Figure 76. Global Cystic Fibrosis Therapeutics Market Size Market Share Forecast by Type (2025-2030) Figure 77. Global Cystic Fibrosis Therapeutics Market Size Market Share Forecast by Application (2025-2030)
